[
  {
    "ts": null,
    "headline": "Cardinal Health (CAH) Laps the Stock Market: Here's Why",
    "summary": "In the closing of the recent trading day, Cardinal Health (CAH) stood at $165.61, denoting a +1.14% move from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=5691fa2a90fb46043cbd51a3792c5b9a20640bcaf5323afd9a7551a06c1d9baf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750975203,
      "headline": "Cardinal Health (CAH) Laps the Stock Market: Here's Why",
      "id": 135582315,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Cardinal Health (CAH) stood at $165.61, denoting a +1.14% move from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=5691fa2a90fb46043cbd51a3792c5b9a20640bcaf5323afd9a7551a06c1d9baf"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "summary": "Cardinal Health Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=3eeb986dbc57cb243f5a2acab89498f2bcc6f956f27b9fbdc8d5b1e196a3ad83",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750956780,
      "headline": "Cardinal Health Inc. stock underperforms Thursday when compared to competitors despite daily gains",
      "id": 135664706,
      "image": "",
      "related": "CAH",
      "source": "MarketWatch",
      "summary": "Cardinal Health Inc. stock underperforms Thursday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=3eeb986dbc57cb243f5a2acab89498f2bcc6f956f27b9fbdc8d5b1e196a3ad83"
    }
  },
  {
    "ts": null,
    "headline": "WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus",
    "summary": "West Pharmaceutical Services rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.",
    "url": "https://finnhub.io/api/news?id=5158bd3aa44f74e9667581966b6e219f74da1fe99a0214fdba48901c8339830b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750941960,
      "headline": "WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus",
      "id": 135558978,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "West Pharmaceutical Services rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.",
      "url": "https://finnhub.io/api/news?id=5158bd3aa44f74e9667581966b6e219f74da1fe99a0214fdba48901c8339830b"
    }
  },
  {
    "ts": null,
    "headline": "Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever",
    "summary": "Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.",
    "url": "https://finnhub.io/api/news?id=3f5b4eff20c4bf2b454db5c6155968888aae19f2fbbc24b107cb648b5d72082c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750941900,
      "headline": "Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever",
      "id": 135558720,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.",
      "url": "https://finnhub.io/api/news?id=3f5b4eff20c4bf2b454db5c6155968888aae19f2fbbc24b107cb648b5d72082c"
    }
  },
  {
    "ts": null,
    "headline": "Is Henry Schein Stock Outperforming the Dow?",
    "summary": "Henry Schein has outperformed the Dow over the past year, and analysts remain moderately optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=63d8f795446e5f1645ee3c573f59c745e759c6c8b0326d70dd8937d862a043c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750930580,
      "headline": "Is Henry Schein Stock Outperforming the Dow?",
      "id": 135554261,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Henry Schein has outperformed the Dow over the past year, and analysts remain moderately optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=63d8f795446e5f1645ee3c573f59c745e759c6c8b0326d70dd8937d862a043c8"
    }
  },
  {
    "ts": null,
    "headline": "5 Must-Read Analyst Questions From Cardinal Health’s Q1 Earnings Call",
    "summary": "Cardinal Health’s first quarter results were received positively by the market, with management attributing performance to strong execution in its Pharmaceutical and Specialty Solutions business and profit growth across all five operating segments. CEO Jason Hollar highlighted that the onboarding of new large customers and the integration of recent acquisitions, such as GI Alliance and Integrated Oncology Network, contributed to both top-line and segment profit gains. CFO Aaron Alt noted that op",
    "url": "https://finnhub.io/api/news?id=a9bb69fc3abacfef3fb811dc4f1501acc0ec564f33e7c7d4b578ed8844ab8774",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750921153,
      "headline": "5 Must-Read Analyst Questions From Cardinal Health’s Q1 Earnings Call",
      "id": 135558883,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal Health’s first quarter results were received positively by the market, with management attributing performance to strong execution in its Pharmaceutical and Specialty Solutions business and profit growth across all five operating segments. CEO Jason Hollar highlighted that the onboarding of new large customers and the integration of recent acquisitions, such as GI Alliance and Integrated Oncology Network, contributed to both top-line and segment profit gains. CFO Aaron Alt noted that op",
      "url": "https://finnhub.io/api/news?id=a9bb69fc3abacfef3fb811dc4f1501acc0ec564f33e7c7d4b578ed8844ab8774"
    }
  },
  {
    "ts": null,
    "headline": "AMG Renaissance Large Cap Growth Fund Q1 2025 Commentary",
    "summary": "AMG Renaissance Large Cap Growth Fund Q1 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=12c634ea1b4f54defb771975c2200276a80fd2218d37a5d411ce651409070485",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750917600,
      "headline": "AMG Renaissance Large Cap Growth Fund Q1 2025 Commentary",
      "id": 135548648,
      "image": "",
      "related": "CAH",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=12c634ea1b4f54defb771975c2200276a80fd2218d37a5d411ce651409070485"
    }
  }
]